ConductScience.org, home

Paper8540697

Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.

van Etten EW and 3 others. Antimicrob Agents Chemother, 1995. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Papers, record 8540697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8540697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2021-05-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Etten EWE W
2ten Kate MTM T
3Stearne LEL E
4Bakker-Woudenberg IAI A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
Antifungal AgentsMajor topic
CandidiasisMajor topic
LeukopeniaMajor topic
Animals
Cyclophosphamide
Drug Carriers
Female
Kidney
Liposomes
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12684010Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2684010PubMed
22184499Amphotericin B: 30 years of clinical experience.Rev Infect Dis1990https://conductscience.org/library/papers/2184499PubMed
32384160Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.FEBS Lett1990https://conductscience.org/library/papers/2384160PubMed
42223816Liposomes for the sustained drug release in vivo.Biochim Biophys Acta1990https://conductscience.org/library/papers/2223816PubMed
58515105Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.J Infect Dis1993https://conductscience.org/library/papers/8515105PubMed
68344999Amphotericin B and its delivery by liposomal and lipid formulations.J Clin Pharm Ther1993https://conductscience.org/library/papers/8344999PubMed
7476012Indium-III: a new radionuclide label for studying human platelet kinetics.Br J Haematol1979https://conductscience.org/library/papers/476012PubMed
88262869Therapeutic efficacy of a liposomal formulation of amphotericin B (AmBisome) against murine blastomycosis.J Antimicrob Chemother1993https://conductscience.org/library/papers/8262869PubMed
98274617New methods of delivery of amphotericin B.Clin Infect Dis1993https://conductscience.org/library/papers/8274617PubMed
108106769
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.
J Infect Dis1994https://conductscience.org/library/papers/8106769PubMed
118125837Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice.J Antimicrob Chemother1993https://conductscience.org/library/papers/8125837PubMed
128169391Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis.J Infect Dis1994https://conductscience.org/library/papers/8169391PubMed
138089064Clinical use of liposomal and lipid-complexed amphotericin B.J Antimicrob Chemother1994https://conductscience.org/library/papers/8089064PubMed
147628985Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.J Antimicrob Chemother1995https://conductscience.org/library/papers/7628985PubMed
1513793161The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid.J Biol Chem1960https://conductscience.org/library/papers/13793161PubMed
162065067Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.Biochim Biophys Acta1991https://conductscience.org/library/papers/2065067PubMed
171911826Pharmacokinetics of stealth versus conventional liposomes: effect of dose.Biochim Biophys Acta1991https://conductscience.org/library/papers/1911826PubMed
181748123Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.Eur J Clin Microbiol Infect Dis1991https://conductscience.org/library/papers/1748123PubMed
191763060Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1763060PubMed
201778892Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents.J Antimicrob Chemother1991https://conductscience.org/library/papers/1778892PubMed

See all 27 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42903468Challenges posed by fungi to host immunity: Mechanisms of immune evasion.Hlife2026https://conductscience.org/library/papers/42903468PubMed
42506291Bridging the "Valley of Death" in Antifungal Therapy: Next-Generation Biomimetic and Exosome-Inspired Nanocarriers for Invasive Candidiasis.J Fungi (Basel)2026https://conductscience.org/library/papers/42506291PubMed
41141727Long-Circulating Liposomes Codelivering Amphotericin B and Retinoic Acid for Cutaneous Leishmaniasis Treatment.ACS Omega2025https://conductscience.org/library/papers/41141727PubMed
38459287Evaluation of the antifungal properties of nanoliposomes containing rhinacanthin-C isolated from the leaves of Rhinacanthus nasutus.World J Microbiol Biotechnol2024https://conductscience.org/library/papers/38459287PubMed
37859317Nanoformulations Insights: A Novel Paradigm for Antifungal Therapies and Future Perspectives.Curr Drug Deliv2024https://conductscience.org/library/papers/37859317PubMed
34032937Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy.Nanoscale Res Lett2021https://conductscience.org/library/papers/34032937PubMed
33622715Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis.mBio2021https://conductscience.org/library/papers/33622715PubMed
31222254Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.Clin Infect Dis2019https://conductscience.org/library/papers/31222254PubMed
29717819Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.Adv Healthc Mater2018https://conductscience.org/library/papers/29717819PubMed
28928478Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Sci Rep2017https://conductscience.org/library/papers/28928478PubMed
26818726Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.Drugs2016https://conductscience.org/library/papers/26818726PubMed
24379661NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.Int J Nanomedicine2013https://conductscience.org/library/papers/24379661PubMed
22544864Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.Pharmacol Rev2012https://conductscience.org/library/papers/22544864PubMed
17722276Optimizing efficacy of amphotericin B through nanomodification.Int J Nanomedicine2006https://conductscience.org/library/papers/17722276PubMed
10817715Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10817715PubMed
10681315Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10681315PubMed
9736579Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9736579PubMed
9736577Superior efficacy of liposomal amphotericin B with prolonged circulation in blood in the treatment of severe candidiasis in leukopenic mice.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9736577PubMed
9624486Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9624486PubMed
9449258Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9449258PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8540697

GET https://conductscience.org/api/papers/v1/8540697/references?page=2